Murray, Clare E.
Kornepati, Anand V. R.
Ontiveros, Carlos
Liao, Yiji
de la Peña Avalos, Bárbara
Rogers, Cody M.
Liu, Zexuan
Deng, Yilun
Bai, Haiyan
Kari, Suresh
Padron, Alvaro S.
Boyd, Jacob T.
Reyes, Ryan
Clark, Curtis A.
Svatek, Robert S.
Li, Rong
Hu, Yanfen
Wang, Meiling
Conejo-Garcia, José R.
Byers, Lauren A.
Ramkumar, Kavya
Sood, Anil K.
Lee, Jung-Min
Burd, Christin E. https://orcid.org/0000-0002-7919-3954
Vadlamudi, Ratna K.
Gupta, Harshita B.
Zhao, Weixing
Dray, Eloïse
Sung, Patrick
Curiel, Tyler J.
Funding for this research was provided by:
National Institutes of Health (CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108, CA239390, GM113896, CA241801, CA054174, CA268641, CA023108)
Article History
Received: 7 February 2024
Accepted: 5 October 2024
First Online: 30 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: TJC and AVK have filed a patent on using PDL1 depleting drugs to treat cancer.